Literature DB >> 29669774

Transient immune-mediated agranulocytosis following Mycoplasma pneumoniae infection.

Luani Barge1, Gail Pahn2, Nicholas Weber1,3.   

Abstract

Mycoplasma pneumoniae is a common respiratory pathogen which may cause haematological manifestations including haemolytic anaemia and thrombocytopaenia. Severe neutropaenia is rare with very few cases reported in the literature. An 85-year-old man was transferred to our facility with agranulocytosis in the context of an infective exacerbation of chronic obstructive pulmonary disease with positive serological testing for M. pneumoniae. No alternative infective, autoimmune or lymphoproliferative cause of the neutropaenia was identified. Granulocyte autoantibody testing was performed with a positive result for neutrophil-bound IgG and IgM autoantibodies and significant agglutination reactions. The patient was treated with azithromycin and granulocyte colony-stimulating factor which resulted in a sustained resolution of his neutropaenia. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (incl blood transfusion); pneumonia (infectious disease)

Mesh:

Substances:

Year:  2018        PMID: 29669774      PMCID: PMC5911146          DOI: 10.1136/bcr-2018-224537

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.

Authors:  Seema Jain; Wesley H Self; Richard G Wunderink; Sherene Fakhran; Robert Balk; Anna M Bramley; Carrie Reed; Carlos G Grijalva; Evan J Anderson; D Mark Courtney; James D Chappell; Chao Qi; Eric M Hart; Frank Carroll; Christopher Trabue; Helen K Donnelly; Derek J Williams; Yuwei Zhu; Sandra R Arnold; Krow Ampofo; Grant W Waterer; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Jonathan A McCullers; Andrew T Pavia; Kathryn M Edwards; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-07-14       Impact factor: 91.245

3.  Colchicine agranulocytosis.

Authors:  D Ducloux; V Schuller; J M Chalopin
Journal:  Nephrol Dial Transplant       Date:  1997-07       Impact factor: 5.992

4.  Allopurinol and agranulocytosis.

Authors:  D G Wilkinson
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

Review 5.  Autoimmune Neutropenia Updates: Etiology, Pathology, and Treatment.

Authors:  Wais Afzal; Mohamad Bagher Owlia; Sarfaraz Hasni; Kam A Newman
Journal:  South Med J       Date:  2017-04       Impact factor: 0.954

Review 6.  Thymoma and agranulocytosis: two case reports and literature review.

Authors:  D Yip; J E Rasko; C Lee; H Kronenberg; B O'Neill
Journal:  Br J Haematol       Date:  1996-10       Impact factor: 6.998

7.  Colchicine-induced toxicity in a heart transplant patient with chronic renal failure.

Authors:  Giorgio Eleftheriou; Guiseppe Bacis; Roberto Fiocchi; Roberta Sebastiano
Journal:  Clin Toxicol (Phila)       Date:  2008-11       Impact factor: 4.467

8.  Mycoplasma pneumoniae infection presenting as neutropenia, thrombocytopenia, and acute hepatitis in a child.

Authors:  Chun-Jung Chen; Chun-Jung Juan; Mu-Ling Hsu; Yuan-Sheng Lai; Shih-Peng Lin; Shin-Nan Cheng
Journal:  J Microbiol Immunol Infect       Date:  2004-04       Impact factor: 4.399

9.  Cold hemagglutinin cross-reactivity with Mycoplasma pneumoniae.

Authors:  F A Janney; L T Lee; C Howe
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

10.  Cephalosporin side chain idiosyncrasies: a case report of ceftriaxone-induced agranulocytosis and review of literature.

Authors:  Natalie Uy; Perumal Thiagarajan; Daniel M Musher
Journal:  Open Forum Infect Dis       Date:  2015-02-14       Impact factor: 3.835

View more
  1 in total

1.  The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota.

Authors:  Yu Jia; Tiantian He; Di Wu; Jiabing Tong; Jie Zhu; Zegeng Li; Jingcheng Dong
Journal:  J Transl Med       Date:  2022-06-21       Impact factor: 8.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.